CRO Pharmatrendz Pvt Ltd

25/04/2025

Empowering Minds, Building Businesses.

25/04/2025

14/03/2025

27/02/2025

Ref : https://timesofindia.indiatimes.com/city/hyderabad/indias-obesity-burden-to-swell-to-rs-6-7l-cr/year-by-2030-study/articleshow/118574684.cms

20/02/2025

20/02/2025

To develop therapies and treatments for everyone, it is important that clinical trial participants come from diverse backgrounds and identities. In this vide...

05/02/2025

https://www.youtube.com/watch?v=euj6I_KD1kA
India - 80 Crore (Million) Obese (3rd rank in World) & 225 Crore
are overweight
By 2034 eleven % of our population will be obese

Blockbuster Weight loss Drug of Novonordisk Ozempic & Wegovy not available in India

What's THE PROBLEM ?

Not legally available in India Yet but few people of India are buying or smuggling the drug and using counterfeit drug sometime.

By Importing from Europe the Cost becoming much higher by shipping, cold storage & custom fees.

Ozempic per month cost $1000 (INR 84,683)

Wegovy cost $1300 (INR 1,10,088)per Month

So its Unaffordable for Indian Population

What's the SOLUTION ?

1) Indian Pharma Giant are working on New Drug Patent Expiry of
Semagutide in 2026
2) India Pharma Company can make generic of Ozempic after
2026. Which will make price lesser.

How Indian Population can get early access now:

1) Once Novonordisk start marketing of drug in in India by 2025
2) By participating in Clinical Trials of generic version of Ozempic
conducted by various Indian Pharma Company

Novo Nordisk and Eli Lilly Battle for a Slice of India’s Obesity Market | Vantage with Palki Sharma2024 saw weight-loss drugs take the world by storm—Ozempic...

01/11/2024

Wishing you a Diwali filled with joy and happiness